---
document_datetime: 2023-09-21 21:27:20
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/riluzole-zentiva-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: riluzole-zentiva-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.9398843
conversion_datetime: 2025-12-19 11:31:42.768134
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Riluzole Zentiva

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|----------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2645/ 202112   | Periodic Safety Update EU Single assessment - riluzole                                       | 15/09/2022                          | 15/11/2022                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/2645/202112. |
| IAIN/0031            | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer | 23/07/2021                          | 06/09/2021                                  | Annex II and PL                  |                                                                                                                                           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    | responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                 |                                   |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------|
| IA/0030            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                   | 03/06/2021 | n/a        |                 |                                   |
| II/0027            | B.I.a.1.g - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a new manufacturer of the AS that is not supported by an ASMF and requires significant update to the relevant AS section in the dossier                                                                                                                                                                                                                                    | 26/11/2020 | n/a        |                 |                                   |
| IA/0028            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                   | 09/09/2020 | 06/09/2021 | Annex II and PL |                                   |
| IA/0029/G          | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 04/09/2020 | n/a        |                 |                                   |
| PSUSA/2645/ 201912 | Periodic Safety Update EU Single assessment - riluzole                                                                                                                                                                                                                                                                                                                                                                                                                                          | 09/07/2020 | n/a        |                 | PRAC Recommendation - maintenance |
| IB/0025            | B.II.b.4.b - Change in the batch size (including batch                                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/02/2020 | n/a        |                 |                                   |

<div style=\"page-break-after: always\"></div>

|                    | size ranges) of the finished product - Downscaling down to 10-fold                                                                                                                                                         |            |            |                                  |                                                                                                                                                                                                                                                                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0024             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                           | 18/09/2018 | 06/09/2021 | PL                               |                                                                                                                                                                                                                                                                                   |
| PSUSA/2645/ 201712 | Periodic Safety Update EU Single assessment - riluzole                                                                                                                                                                     | 12/07/2018 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                 |
| T/0023             | Transfer of Marketing Authorisation                                                                                                                                                                                        | 17/04/2018 | 08/05/2018 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                   |
| R/0021             | Renewal of the marketing authorisation.                                                                                                                                                                                    | 10/11/2016 | 09/01/2017 | SmPC, Annex II, Labelling and PL | Based on on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Riluzole Zentiva in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/2645/ 201512 | Periodic Safety Update EU Single assessment - riluzole                                                                                                                                                                     | 02/09/2016 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                 |
| N/0020             | Update of the package leaflet with revised contact details of the local representatives for Hungary, Italy and Lithuania. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 31/03/2016 | 09/01/2017 | PL                               |                                                                                                                                                                                                                                                                                   |
| N/0018             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                           | 05/11/2015 | 09/01/2017 | PL                               |                                                                                                                                                                                                                                                                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0017          | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   | 28/07/2015   | n/a        |    |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|-----------------------------------|
| N/0016             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                         | 16/07/2015   | 09/01/2017 | PL |                                   |
| N/0015             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                         | 07/11/2014   | 09/01/2017 | PL |                                   |
| PSUSA/2645/ 201312 | Periodic Safety Update EU Single assessment - riluzole                                                                                                                                                                                   | 11/09/2014   | n/a        |    | PRAC Recommendation - maintenance |
| IA/0014            | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                         | 12/08/2014   | n/a        |    |                                   |
| IAIN/0013          | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer                           | 05/08/2014   | n/a        |    |                                   |
| IG/0454            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                          | 17/07/2014   | n/a        |    |                                   |
| N/0010             | Minor change in labelling or package leaflet not                                                                                                                                                                                         | 27/03/2014   | 11/07/2014 | PL |                                   |

<div style=\"page-break-after: always\"></div>

|             | connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                              |            |            |                                  |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| IB/0009     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                               | 18/12/2013 | 11/07/2014 | SmPC, Annex II, Labelling and PL |
| IA/0008/G   | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                               | 18/11/2013 | n/a        |                                  |
| IAIN/0007/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 12/09/2013 | 11/07/2014 | Annex II and PL                  |
| IG/0314     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                               | 08/07/2013 | n/a        |                                  |
| IB/0005/G   | This was an application for a group of variations. B.II.d.1.z - Change in the specification parameters                                                                                                                                                                                                                                                                                       | 04/07/2013 | n/a        |                                  |

<div style=\"page-break-after: always\"></div>

|           | limits of the finished product - Other variation - Change in the specification parameters limits of the finished product - Other variation - Change in the specification parameters limits of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                                  | and/or B.II.d.1.z and/or B.II.d.1.z and/or   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------|
| IB/0004/G | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside of the currently approved pack sizes | 03/07/2013 | 11/07/2014 | SmPC, Annex II, Labelling and PL | the range                                    |
| IB/0003   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 15/01/2013 | n/a        |                                  |                                              |
| N/0002    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 29/10/2012 | 11/07/2014 | PL                               |                                              |

<div style=\"page-break-after: always\"></div>

| IG/0192   | C.I.9.i - Changes to an existing pharmacovigilance   | 06/07/2012   | n/a   | system DDPS relation MAH   |
|-----------|------------------------------------------------------|--------------|-------|----------------------------|